Trial Profile
Clinical Trials Insight: 700029931
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Jan 2008
Price :
$35
*
At a glance
- Drugs Ethyl eicosapentaenoic acid (Primary)
- Indications Memory disorders
- Focus Therapeutic Use
- Sponsors Amarin Corporation
- 17 Jan 2008 New trial record.